Lockheed Martin Corporation (LMT), Raytheon Company (RTN) & 15 Anti-Terror Stocks To Watch

Page 8 of 14

Cepheid (NASDAQ:CPHD)

Market Cap: $2.47 billion, Forward PE: 154.08, ROE: -8.73%

Cepheid (NASDAQ:CPHD) is a company specialized in molecular diagnostics, it develops and produces systems for testing in the clinical market. According to Yahoo! Finance, Cepheid (NASDAQ:CPHD)’s systems enable molecular testing for organisms and genetic-based diseases by automating manual laboratory procedures. The company offers GeneXpert system that integrates sample preparation in addition to DNA amplification and detection; and SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.

Page 8 of 14